Pharma & Healthcare

Global Rituximab Market Research Report 2025

Report Scope
This report aims to provide a comprehensive presentation of the global market for Rituximab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rituximab.
The Rituximab market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rituximab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rituximab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche
Pfizer
Biogen
Teva
Segment by Type
500mg
100mg
Segment by Application
Intravenous Use
Subcutaneous Use
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rituximab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rituximab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
1 Rituximab Market Overview
1.1 Product Definition
1.2 Rituximab by Type
1.2.1 Global Rituximab Market Value Comparison by Type (2024 VS 2031)
1.2.2 500mg
1.2.3 100mg
1.3 Rituximab by Application
1.3.1 Global Rituximab Market Value by Application (2024 VS 2031)
1.3.2 Intravenous Use
1.3.3 Subcutaneous Use
1.4 Global Rituximab Market Size Estimates and Forecasts
1.4.1 Global Rituximab Revenue 2020-2031
1.4.2 Global Rituximab Sales 2020-2031
1.4.3 Global Rituximab Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rituximab Market Competition by Manufacturers
2.1 Global Rituximab Sales Market Share by Manufacturers (2020-2025)
2.2 Global Rituximab Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Rituximab Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rituximab, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rituximab, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rituximab, Product Type & Application
2.7 Global Key Manufacturers of Rituximab, Date of Enter into This Industry
2.8 Global Rituximab Market Competitive Situation and Trends
2.8.1 Global Rituximab Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rituximab Players Market Share by Revenue
2.8.3 Global Rituximab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rituximab Market Scenario by Region
3.1 Global Rituximab Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rituximab Sales by Region: 2020-2031
3.2.1 Global Rituximab Sales by Region: 2020-2025
3.2.2 Global Rituximab Sales by Region: 2026-2031
3.3 Global Rituximab Revenue by Region: 2020-2031
3.3.1 Global Rituximab Revenue by Region: 2020-2025
3.3.2 Global Rituximab Revenue by Region: 2026-2031
3.4 North America Rituximab Market Facts & Figures by Country
3.4.1 North America Rituximab Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rituximab Sales by Country (2020-2031)
3.4.3 North America Rituximab Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Rituximab Market Facts & Figures by Country
3.5.1 Europe Rituximab Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rituximab Sales by Country (2020-2031)
3.5.3 Europe Rituximab Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rituximab Market Facts & Figures by Region
3.6.1 Asia Pacific Rituximab Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rituximab Sales by Region (2020-2031)
3.6.3 Asia Pacific Rituximab Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rituximab Market Facts & Figures by Country
3.7.1 Latin America Rituximab Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rituximab Sales by Country (2020-2031)
3.7.3 Latin America Rituximab Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rituximab Market Facts & Figures by Country
3.8.1 Middle East and Africa Rituximab Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rituximab Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rituximab Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rituximab Sales by Type (2020-2031)
4.1.1 Global Rituximab Sales by Type (2020-2025)
4.1.2 Global Rituximab Sales by Type (2026-2031)
4.1.3 Global Rituximab Sales Market Share by Type (2020-2031)
4.2 Global Rituximab Revenue by Type (2020-2031)
4.2.1 Global Rituximab Revenue by Type (2020-2025)
4.2.2 Global Rituximab Revenue by Type (2026-2031)
4.2.3 Global Rituximab Revenue Market Share by Type (2020-2031)
4.3 Global Rituximab Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rituximab Sales by Application (2020-2031)
5.1.1 Global Rituximab Sales by Application (2020-2025)
5.1.2 Global Rituximab Sales by Application (2026-2031)
5.1.3 Global Rituximab Sales Market Share by Application (2020-2031)
5.2 Global Rituximab Revenue by Application (2020-2031)
5.2.1 Global Rituximab Revenue by Application (2020-2025)
5.2.2 Global Rituximab Revenue by Application (2026-2031)
5.2.3 Global Rituximab Revenue Market Share by Application (2020-2031)
5.3 Global Rituximab Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Rituximab Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Rituximab Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Rituximab Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Rituximab Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Biogen
6.3.1 Biogen Company Information
6.3.2 Biogen Description and Business Overview
6.3.3 Biogen Rituximab Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biogen Rituximab Product Portfolio
6.3.5 Biogen Recent Developments/Updates
6.4 Teva
6.4.1 Teva Company Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Rituximab Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Rituximab Product Portfolio
6.4.5 Teva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rituximab Industry Chain Analysis
7.2 Rituximab Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rituximab Production Mode & Process Analysis
7.4 Rituximab Sales and Marketing
7.4.1 Rituximab Sales Channels
7.4.2 Rituximab Distributors
7.5 Rituximab Customer Analysis
8 Rituximab Market Dynamics
8.1 Rituximab Industry Trends
8.2 Rituximab Market Drivers
8.3 Rituximab Market Challenges
8.4 Rituximab Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Rituximab Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Rituximab Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Rituximab Market Competitive Situation by Manufacturers in 2024
Table 4. Global Rituximab Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Rituximab Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Rituximab Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Rituximab Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Rituximab Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Rituximab, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Rituximab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rituximab, Product Type & Application
Table 12. Global Key Manufacturers of Rituximab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rituximab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rituximab as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rituximab Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Rituximab Sales by Region (2020-2025) & (K Units)
Table 18. Global Rituximab Sales Market Share by Region (2020-2025)
Table 19. Global Rituximab Sales by Region (2026-2031) & (K Units)
Table 20. Global Rituximab Sales Market Share by Region (2026-2031)
Table 21. Global Rituximab Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Rituximab Revenue Market Share by Region (2020-2025)
Table 23. Global Rituximab Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Rituximab Revenue Market Share by Region (2026-2031)
Table 25. North America Rituximab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Rituximab Sales by Country (2020-2025) & (K Units)
Table 27. North America Rituximab Sales by Country (2026-2031) & (K Units)
Table 28. North America Rituximab Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Rituximab Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Rituximab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Rituximab Sales by Country (2020-2025) & (K Units)
Table 32. Europe Rituximab Sales by Country (2026-2031) & (K Units)
Table 33. Europe Rituximab Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Rituximab Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Rituximab Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Rituximab Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Rituximab Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Rituximab Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Rituximab Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Rituximab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Rituximab Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Rituximab Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Rituximab Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Rituximab Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Rituximab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Rituximab Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Rituximab Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Rituximab Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Rituximab Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Rituximab Sales (K Units) by Type (2020-2025)
Table 51. Global Rituximab Sales (K Units) by Type (2026-2031)
Table 52. Global Rituximab Sales Market Share by Type (2020-2025)
Table 53. Global Rituximab Sales Market Share by Type (2026-2031)
Table 54. Global Rituximab Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Rituximab Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Rituximab Revenue Market Share by Type (2020-2025)
Table 57. Global Rituximab Revenue Market Share by Type (2026-2031)
Table 58. Global Rituximab Price (USD/Unit) by Type (2020-2025)
Table 59. Global Rituximab Price (USD/Unit) by Type (2026-2031)
Table 60. Global Rituximab Sales (K Units) by Application (2020-2025)
Table 61. Global Rituximab Sales (K Units) by Application (2026-2031)
Table 62. Global Rituximab Sales Market Share by Application (2020-2025)
Table 63. Global Rituximab Sales Market Share by Application (2026-2031)
Table 64. Global Rituximab Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Rituximab Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Rituximab Revenue Market Share by Application (2020-2025)
Table 67. Global Rituximab Revenue Market Share by Application (2026-2031)
Table 68. Global Rituximab Price (USD/Unit) by Application (2020-2025)
Table 69. Global Rituximab Price (USD/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Rituximab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Roche Rituximab Product
Table 74. Roche Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Rituximab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer Rituximab Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Biogen Company Information
Table 81. Biogen Description and Business Overview
Table 82. Biogen Rituximab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Biogen Rituximab Product
Table 84. Biogen Recent Developments/Updates
Table 85. Teva Company Information
Table 86. Teva Description and Business Overview
Table 87. Teva Rituximab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Teva Rituximab Product
Table 89. Teva Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Rituximab Distributors List
Table 93. Rituximab Customers List
Table 94. Rituximab Market Trends
Table 95. Rituximab Market Drivers
Table 96. Rituximab Market Challenges
Table 97. Rituximab Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report


List of Figures
Figure 1. Product Picture of Rituximab
Figure 2. Global Rituximab Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Rituximab Market Share by Type: 2024 & 2031
Figure 4. 500mg Product Picture
Figure 5. 100mg Product Picture
Figure 6. Global Rituximab Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Rituximab Market Share by Application: 2024 & 2031
Figure 8. Intravenous Use
Figure 9. Subcutaneous Use
Figure 10. Global Rituximab Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Rituximab Market Size (2020-2031) & (US$ Million)
Figure 12. Global Rituximab Sales (2020-2031) & (K Units)
Figure 13. Global Rituximab Average Price (USD/Unit) & (2020-2031)
Figure 14. Rituximab Report Years Considered
Figure 15. Rituximab Sales Share by Manufacturers in 2024
Figure 16. Global Rituximab Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Rituximab Players: Market Share by Revenue in Rituximab in 2024
Figure 18. Rituximab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Rituximab Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Rituximab Sales Market Share by Country (2020-2031)
Figure 21. North America Rituximab Revenue Market Share by Country (2020-2031)
Figure 22. the United States Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Rituximab Sales Market Share by Country (2020-2031)
Figure 25. Europe Rituximab Revenue Market Share by Country (2020-2031)
Figure 26. Germany Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. UK Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Rituximab Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Rituximab Revenue Market Share by Region (2020-2031)
Figure 33. China Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Rituximab Sales Market Share by Country (2020-2031)
Figure 43. Latin America Rituximab Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Rituximab Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Rituximab Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Rituximab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Rituximab by Type (2020-2031)
Figure 53. Global Revenue Market Share of Rituximab by Type (2020-2031)
Figure 54. Global Rituximab Price (USD/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Rituximab by Application (2020-2031)
Figure 56. Global Revenue Market Share of Rituximab by Application (2020-2031)
Figure 57. Global Rituximab Price (USD/Unit) by Application (2020-2031)
Figure 58. Rituximab Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies